Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / nopa-analysis-memo.docx
nopa-analysis-memo.docx
Parties
Harkness LLP
Penterra Pharmaceuticals Corp
Penterra's Corp
IP Arrangement Penterra Pharmaceuticals Corp
Penterra Manufacturing Ireland Ltd
Associates LLP
Whitmore Valuation Group LLC
Altera Corp
Dates
October 20, 2023
October 12, 2023
May 16, 2022
November 8, 2023
March 15, 2012
July 1, 2012
July 12, 2022
June 2, 2022
June 8, 2022
June 20, 2022
Amounts
$380,400,000
$235,010,000
$188,040,000
$42,650,000
$380.4
$79.88
$15,977,000
$15.98
$6.82
$1.47
Obligations
Section 482 is the foundational authority for all transfer pricing adjustments and requires that controlled transactions be consistent with an arm's-length standard — that is, the results of controlled transactions must be consistent with the results that would have been realized if uncontrolled taxpayers had engaged in the same transaction under the same circumstances
However, as discussed below, the application of these provisions is subject to significant limitations and must be distinguished from a wholesale recharacterization of the cost-sharing ratios based on hindsight
• Exclusivity terms: Differences in exclusivity provisions, co-promotion rights, and termination provisions can significantly affect royalty rates and must be accounted for in a CUT analysis
482-1(g), the IRS is required to take into account the effect of any allocation under § 482 on other related transactions
Nevertheless, the argument has strategic significance because it could be deployed as leverage in settlement negotiations or at Appeals, and it must be addressed comprehensively in the Protest to prevent it from gaining traction